Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drug

Enbrel Mini(Etanercept)Amgen Inc. logoAMGN

Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Amgen Inc.

$255.6M

Medicare cost, 2024

Medicare drug plans spent $255.6 million on Enbrel Mini (etanercept) in 2024, for 32,406 prescriptions and refills filled by 4,127 patients. At about $7,887 per prescription it is a high-cost drug. Texas accounts for the most spending ($29.5 million, 12% of the total). It is made by Amgen Inc. (AMGN).

Medicare cost, 2024

$255.6M

-4.9% from 2023

Prescriptions

32K

$7,887.31 per claim

Patients

4,127

2,278 prescribers

Total spending, 2024

$255.6M

$61,924.32 per patient

Questions and answers

How much does Medicare spend on Enbrel Mini?

Medicare prescription drug plans paid $255.6M for Enbrel Mini in 2024, for 32,406 prescriptions and refills to 4,127 patients (down 4.9% from 2023). The average cost per claim was $7,887.31.

Which state spends the most on Enbrel Mini?

Texas had the highest Medicare cost for Enbrel Mini in 2024: $29.5M for 3,720 claims, followed by Florida ($27.2M).

Who prescribes Enbrel Mini the most?

Jolanta Sobotka-Czarnecki, rheumatology in Flint, MI, had the highest Medicare cost for Enbrel Mini in 2024: 433 claims costing $3.2M.

Who makes Enbrel Mini?

Enbrel Mini is made by Amgen Inc. (AMGN), listed in the Medicare spending data as Amgen.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Enbrel Mini was $255.6M in 2024, after a high of $269.0M in 2023.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Enbrel Mini, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Jolanta Sobotka-Czarnecki Flint, MIRheumatology43347$3.2M
Amanda L Matthews San Antonio, TXPhysician Assistant31544$2.5M
Mansoor Ahmed Richmond, KYRheumatology33555$2.4M
Syed H Raza Memphis, TNRheumatology33638$2.4M
Ann Aleman Weinmann Corpus Christi, TXInternal Medicine26031$2.2M
Naiara Alvarez Harlingen, TXRheumatology29037$2.1M
Padmanaidu Karnam Watkinsville, GARheumatology20330$1.6M
Veronica K Newsome Du Bois, PARheumatology18629$1.5M
Jyothi R Mallepalli Monroe, LARheumatology17923$1.4M
Rakesh C Patel Salisbury, NCRheumatology18825$1.4M
Hasan Abualula Summerfield, FLRheumatology16420$1.2M
Gurjot K Basra Lake Charles, LARheumatology14934$1.1M
Michael Babilonia Roman Mayaguez, PRInternal Medicine13914$1.0M
Hollie S Donnelly Lake Charles, LANurse Practitioner13228$1.0M
Kyla Lokitz Shreveport, LAInternal Medicine12817$952K
Richa Gupta Gulfport, MSRheumatology13025$947K
James E Mossell III Tifton, GARheumatology12317$914K
James W Logan Boone, NCRheumatology11614$883K
Ebrahim Talebi Quje Catonsville, MDRheumatology10814$867K
Asim Razzaq Murfreesboro, TNRheumatology10913$834K
Yong H Tsai Daytona Beach, FLRheumatology9513$807K
David G Stainbrook Jr. Du Bois, PARheumatology9912$805K
Liangyong Jiang Greenville, NCRheumatology10613$804K
Sailaja P Manne San Antonio, TXInternal Medicine9518$792K
Robert J Meador Jr. Ithaca, NYRheumatology9412$769K

Prescriber data by year

YearPrescribersClaimsPatientsCost
20222,43736,0094,884$259.7M
20232,35234,5784,483$268.9M
20242,27832,4064,127$255.6M

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
AmgenAMGN logoAMGN32,410$255.6M

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube